Ziekenhuis Netwerk Antwerpen
Ziekenhuis Netwerk Antwerpen
Antwerp, Belgium4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-10-01 | NCT02227251 | |
| Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2026-07-08 | NCT04685616 | |
| Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, digestive system neuroendocrine neoplasm, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 4 | 2024-06-14 | NCT05701241 | |
| Validation of the O-bridge Protocol: a Prospective, Multicenter Trial | Benign or Malignant Tumour of the Oral Cavity; Fixed Dental Restoration; Mandibular Reconstruction; Quality of Life; Stage III-IV Osteonecrosis | Recruiting | Not stated | 2022-02-24 | NCT04007783 |